MedPath

Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest

Phase 2
Completed
Conditions
Out-Of-Hospital Cardiac Arrest
Interventions
Drug: Placebo
Drug: sodium nitrite 45 mg
Drug: sodium nitrite 60 mg
Registration Number
NCT03452917
Lead Sponsor
University of Washington
Brief Summary

In this clinical study, a total of 1500 patients with out-of-hospital cardiac arrest in Seattle/King County will be enrolled. This will be a randomized clinical trial and patients will receive either two different doses of IV sodium nitrite (45 mg or 60 mg) or placebo during resuscitation in the field by paramedics. The primary outcome will be proportion of patients surviving to hospital admission.

Detailed Description

The hemodynamic effects of the optimal dose of IV nitrite administered in patients with cardiac arrest are unknown. A significant negative hemodynamic effect from nitrite would decrease the proportion of patients admitted to the hospital, increase rate of re-arrest, or increase the need for vasopressor support in the field. In Seattle/King County, typically 40% of out-of-hospital cardiac arrest patients attended to by paramedics have Return of spontaneous circulation (ROSC) and are admitted to the hospital. In this study, 1500 patients with out-of-hospital cardiac arrest who are undergoing resuscitation by paramedics will be randomized to receive placebo (n=500) or 45 mg IV (n=500) or 60 mg dose (n=500) of sodium nitrite. The study will have 80% power to detect an absolute increase in hospital admission rate of 8% (1-sided .05 level test for each of the two comparisons (45 mg vs placebo and 60 mg vs placebo, no adjustment for multiple comparisons), with a hospital admission rate of 40% in the placebo group and with one interim analysis and stopping only for potential futility and/or harm). The investigators will examine the proportion of patients who survive to discharge as a secondary measure of efficacy.

Patients will be eligible for this study if:

1. Intravenous access (IV)/intraosseous access(IO)

2. Cardiac arrest, either Ventricular Fibrillation (VF) or non-VF patients receiving Advanced Cardiac Life Support (ACLS) by Seattle/King County paramedics.

3. Age 18 years or older

4. Comatose

Exclusion Criteria

1. Traumatic cause of cardiac arrest

2. Prisoner, pregnancy, age less than 18 (special population/vulnerable population)

3. Known DNAR

4. Drowning as cause of arrest.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1502
Inclusion Criteria
  • Cardiac arrest, either VF or non-VF, patients receiving ACLS by paramedics
  • IV or IO access
  • Comatose
Exclusion Criteria
  • traumatic cause of cardiac arrest
  • prisoner, pregnancy
  • known DNAR

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo2 ml of normal saline (n=500)
sodium nitritesodium nitrite 45 mg45 mg IV of sodium nitrite (n=500) or 60 mg IV sodium nitrite (n=500) given during active resuscitation from out of hospital cardiac arrest.
sodium nitritesodium nitrite 60 mg45 mg IV of sodium nitrite (n=500) or 60 mg IV sodium nitrite (n=500) given during active resuscitation from out of hospital cardiac arrest.
Primary Outcome Measures
NameTimeMethod
Number of Participants Who Survived to Hospital Admissionwithin 24 hours after out of hospital cardiac arrest

Patient has sustained pulse at arrival to the emergency department

Secondary Outcome Measures
NameTimeMethod
Survival to 24 Hourswithin first 24 h after hospital admission

Patient is alive after the first 24 hours after admission to the hospital

Number of Days in ICUWithin first 3 months of hospital admission

Number of days the patient is admitted to the Intensive Care Unit

Survival to Dischargewithin 3-6 months after cardiac arrest

Patient alive at time of discharge from hospital

Re-arrestbefore hospital arrival

Patient loses pulses during transport to the hospital. Event occurs before admission to hospital.

Survival to 48 Hours After Admission to Hospitalwithin first 48 hours after admission to hospital

Patient is alive after first 48 hours after admission to the hospital

Survival to 72 Hours After Admission to Hospitalwithin first 72 hours after admission to hospital

Patient is alive after first 72 hours after admission to the hospital

Trial Locations

Locations (1)

Harborview Medical Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath